Global and Plasma Derived Medicine Market Insights, Forecast to 2026

Publisher Name :
Date: 15-Sep-2020
No. of pages: 142
Inquire Before Buying

Plasma Derived Medicine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Plasma Derived Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment , the Plasma Derived Medicine market is segmented into

- Albumin

- Coagulation Factor

- Immunoglobulin

- Others

Segment 5, the Plasma Derived Medicine market is segmented into

- Hospitals

- Clinics

- Other

Regional and Country-level Analysis

The Plasma Derived Medicine market is analysed and market size information is provided by regions (countries).

The key regions covered in the Plasma Derived Medicine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, United States, Canada, Germany, France, UK, Italy, Russia, China, Japan, South Korea, India, Australia, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Brazil, Turkey, GCC Countries, Egypt, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast , and 5 segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Plasma Derived Medicine Market Share Analysis

Plasma Derived Medicine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Plasma Derived Medicine business, the date to enter into the Plasma Derived Medicine market, Plasma Derived Medicine product introduction, recent developments, etc.

The major vendors covered:

- Grifols

- SK Plasma

- Fusion Health Care

- Biotest AG

- GC Pharma

- Baxter International

- LFB

- Octapharma AG

- CSL Limited

- BPL

- China Biologic Products

- Kedrion Biopharma

- RAAS

- Tiantan Bio

- Hualan Biological Engineering

- BOYA Bio-Pharmaceutical

Global and Plasma Derived Medicine Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Plasma Derived Medicine Product Introduction
1.2 Market Segments
1.3 Key Plasma Derived Medicine Manufacturers Covered: Ranking by Revenue
1.4 Market
1.4.1 Global Plasma Derived Medicine Market Size Growth Rate
1.4.2 Albumin
1.4.3 Coagulation Factor
1.4.4 Immunoglobulin
1.4.5 Others
1.5 Market 5
1.5.1 Global Plasma Derived Medicine Market Size Growth Rate 5
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Plasma Derived Medicine Market Size, Estimates and Forecasts
2.1.1 Global Plasma Derived Medicine Revenue 2015-2026
2.1.2 Global Plasma Derived Medicine Sales 2015-2026
2.2 Global Plasma Derived Medicine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Plasma Derived Medicine Historical Market Size by Region (2015-2020)
2.3.1 Global Plasma Derived Medicine Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Plasma Derived Medicine Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Plasma Derived Medicine Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Plasma Derived Medicine Sales Forecast by Region (2021-2026)
2.4.2 Global Plasma Derived Medicine Revenue Forecast by Region (2021-2026)
3 Global Plasma Derived Medicine Competitor Landscape by Players
3.1 Global Top Plasma Derived Medicine Sales by Manufacturers
3.1.1 Global Plasma Derived Medicine Sales by Manufacturers (2015-2020)
3.1.2 Global Plasma Derived Medicine Sales Market Share by Manufacturers (2015-2020)
3.2 Global Plasma Derived Medicine Manufacturers by Revenue
3.2.1 Global Plasma Derived Medicine Revenue by Manufacturers (2015-2020)
3.2.2 Global Plasma Derived Medicine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Plasma Derived Medicine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Plasma Derived Medicine Revenue in 2019
3.2.5 Global Plasma Derived Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Plasma Derived Medicine Price by Manufacturers
3.4 Global Plasma Derived Medicine Manufacturing Base Distribution, Product Types
3.4.1 Plasma Derived Medicine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Plasma Derived Medicine Product Type
3.4.3 Date of International Manufacturers Enter into Plasma Derived Medicine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size (2015-2026)
4.1 Global Plasma Derived Medicine Market Size (2015-2020)
4.1.1 Global Plasma Derived Medicine Sales (2015-2020)
4.1.2 Global Plasma Derived Medicine Revenue (2015-2020)
4.1.3 Plasma Derived Medicine Average Selling Price (ASP) (2015-2026)
4.2 Global Plasma Derived Medicine Market Size Forecast (2021-2026)
4.2.1 Global Plasma Derived Medicine Sales Forecast (2021-2026)
4.2.2 Global Plasma Derived Medicine Revenue Forecast (2021-2026)
4.2.3 Plasma Derived Medicine Average Selling Price (ASP) Forecast (2021-2026)
4.3 Global Plasma Derived Medicine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size 5 (2015-2026)
5.1 Global Plasma Derived Medicine Market Size 5 (2015-2020)
5.1.1 Global Plasma Derived Medicine Sales 5 (2015-2020)
5.1.2 Global Plasma Derived Medicine Revenue 5 (2015-2020)
5.1.3 Plasma Derived Medicine Price 5 (2015-2020)
5.2 Plasma Derived Medicine Market Size Forecast 5 (2021-2026)
5.2.1 Global Plasma Derived Medicine Sales Forecast 5 (2021-2026)
5.2.2 Global Plasma Derived Medicine Revenue Forecast 5 (2021-2026)
5.2.3 Global Plasma Derived Medicine Price Forecast 5 (2021-2026)
6 by Players, and
6.1 Plasma Derived Medicine Market Size YoY Growth 2015-2026
6.1.1 Plasma Derived Medicine Sales YoY Growth 2015-2026
6.1.2 Plasma Derived Medicine Revenue YoY Growth 2015-2026
6.1.3 Plasma Derived Medicine Market Share in Global Market 2015-2026
6.2 Plasma Derived Medicine Market Size by Players (International and Local Players)
6.2.1 Top Plasma Derived Medicine Players by Sales (2015-2020)
6.2.2 Top Plasma Derived Medicine Players by Revenue (2015-2020)
6.3 Plasma Derived Medicine Historic Market Review (2015-2020)
6.3.1 Plasma Derived Medicine Sales Market Share (2015-2020)
6.3.2 Plasma Derived Medicine Revenue Market Share (2015-2020)
6.3.3 Plasma Derived Medicine Price (2015-2020)
6.4 Plasma Derived Medicine Market Estimates and Forecasts (2021-2026)
6.4.1 Plasma Derived Medicine Sales Forecast (2021-2026)
6.4.2 Plasma Derived Medicine Revenue Forecast (2021-2026)
6.4.3 Plasma Derived Medicine Price Forecast (2021-2026)
6.5 Plasma Derived Medicine Historic Market Review 5 (2015-2020)
6.5.1 Plasma Derived Medicine Sales Market Share 5 (2015-2020)
6.5.2 Plasma Derived Medicine Revenue Market Share 5 (2015-2020)
6.5.3 Plasma Derived Medicine Price 5 (2015-2020)
6.6 Plasma Derived Medicine Market Estimates and Forecasts 5 (2021-2026)
6.6.1 Plasma Derived Medicine Sales Forecast 5 (2021-2026)
6.6.2 Plasma Derived Medicine Revenue Forecast 5 (2021-2026)
6.6.3 Plasma Derived Medicine Price Forecast 5 (2021-2026)
7 North America
7.1 North America Plasma Derived Medicine Market Size YoY Growth 2015-2026
7.2 North America Plasma Derived Medicine Market Facts & Figures by Country
7.2.1 North America Plasma Derived Medicine Sales by Country (2015-2020)
7.2.2 North America Plasma Derived Medicine Revenue by Country (2015-2020)
7.2.3 United States
7.2.4 Canada
7.2.5 Mexico
8 Europe
8.1 Europe Plasma Derived Medicine Market Size YoY Growth 2015-2026
8.2 Europe Plasma Derived Medicine Market Facts & Figures by Country
8.2.1 Europe Plasma Derived Medicine Sales by Country
8.2.2 Europe Plasma Derived Medicine Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 UK
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Plasma Derived Medicine Market Size YoY Growth 2015-2026
9.2 Asia Pacific Plasma Derived Medicine Market Facts & Figures by Country
9.2.1 Asia Pacific Plasma Derived Medicine Sales by Region (2015-2020)
9.2.2 Asia Pacific Plasma Derived Medicine Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Indonesia
9.2.9 Thailand
9.2.10 Malaysia
9.2.11 Philippines
9.2.12 Vietnam
10 Latin America
10.1 Latin America Plasma Derived Medicine Market Size YoY Growth 2015-2026
10.2 Latin America Plasma Derived Medicine Market Facts & Figures by Country
10.2.1 Latin America Plasma Derived Medicine Sales by Country
10.2.2 Latin America Plasma Derived Medicine Revenue by Country
10.2.3 Brazil
11 Middle East and Africa
11.1 Middle East and Africa Plasma Derived Medicine Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Plasma Derived Medicine Market Facts & Figures by Country
11.2.1 Middle East and Africa Plasma Derived Medicine Sales by Country
11.2.2 Middle East and Africa Plasma Derived Medicine Revenue by Country
11.2.3 Turkey
11.2.4 GCC Countries
11.2.5 Egypt
11.2.6 South Africa
12 Company Profiles
12.1 Grifols
12.1.1 Grifols Corporation Information
12.1.2 Grifols Description and Business Overview
12.1.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Grifols Plasma Derived Medicine Products Offered
12.1.5 Grifols Recent Development
12.2 SK Plasma
12.2.1 SK Plasma Corporation Information
12.2.2 SK Plasma Description and Business Overview
12.2.3 SK Plasma Sales, Revenue and Gross Margin (2015-2020)
12.2.4 SK Plasma Plasma Derived Medicine Products Offered
12.2.5 SK Plasma Recent Development
12.3 Fusion Health Care
12.3.1 Fusion Health Care Corporation Information
12.3.2 Fusion Health Care Description and Business Overview
12.3.3 Fusion Health Care Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Fusion Health Care Plasma Derived Medicine Products Offered
12.3.5 Fusion Health Care Recent Development
12.4 Biotest AG
12.4.1 Biotest AG Corporation Information
12.4.2 Biotest AG Description and Business Overview
12.4.3 Biotest AG Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Biotest AG Plasma Derived Medicine Products Offered
12.4.5 Biotest AG Recent Development
12.5 GC Pharma
12.5.1 GC Pharma Corporation Information
12.5.2 GC Pharma Description and Business Overview
12.5.3 GC Pharma Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GC Pharma Plasma Derived Medicine Products Offered
12.5.5 GC Pharma Recent Development
12.6 Baxter International
12.6.1 Baxter International Corporation Information
12.6.2 Baxter International Description and Business Overview
12.6.3 Baxter International Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Baxter International Plasma Derived Medicine Products Offered
12.6.5 Baxter International Recent Development
12.7 LFB
12.7.1 LFB Corporation Information
12.7.2 LFB Description and Business Overview
12.7.3 LFB Sales, Revenue and Gross Margin (2015-2020)
12.7.4 LFB Plasma Derived Medicine Products Offered
12.7.5 LFB Recent Development
12.8 Octapharma AG
12.8.1 Octapharma AG Corporation Information
12.8.2 Octapharma AG Description and Business Overview
12.8.3 Octapharma AG Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Octapharma AG Plasma Derived Medicine Products Offered
12.8.5 Octapharma AG Recent Development
12.9 CSL Limited
12.9.1 CSL Limited Corporation Information
12.9.2 CSL Limited Description and Business Overview
12.9.3 CSL Limited Sales, Revenue and Gross Margin (2015-2020)
12.9.4 CSL Limited Plasma Derived Medicine Products Offered
12.9.5 CSL Limited Recent Development
12.10 BPL
12.10.1 BPL Corporation Information
12.10.2 BPL Description and Business Overview
12.10.3 BPL Sales, Revenue and Gross Margin (2015-2020)
12.10.4 BPL Plasma Derived Medicine Products Offered
12.10.5 BPL Recent Development
12.11 Grifols
12.11.1 Grifols Corporation Information
12.11.2 Grifols Description and Business Overview
12.11.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Grifols Plasma Derived Medicine Products Offered
12.11.5 Grifols Recent Development
12.12 Kedrion Biopharma
12.12.1 Kedrion Biopharma Corporation Information
12.12.2 Kedrion Biopharma Description and Business Overview
12.12.3 Kedrion Biopharma Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Kedrion Biopharma Products Offered
12.12.5 Kedrion Biopharma Recent Development
12.13 RAAS
12.13.1 RAAS Corporation Information
12.13.2 RAAS Description and Business Overview
12.13.3 RAAS Sales, Revenue and Gross Margin (2015-2020)
12.13.4 RAAS Products Offered
12.13.5 RAAS Recent Development
12.14 Tiantan Bio
12.14.1 Tiantan Bio Corporation Information
12.14.2 Tiantan Bio Description and Business Overview
12.14.3 Tiantan Bio Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Tiantan Bio Products Offered
12.14.5 Tiantan Bio Recent Development
12.15 Hualan Biological Engineering
12.15.1 Hualan Biological Engineering Corporation Information
12.15.2 Hualan Biological Engineering Description and Business Overview
12.15.3 Hualan Biological Engineering Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Hualan Biological Engineering Products Offered
12.15.5 Hualan Biological Engineering Recent Development
12.16 BOYA Bio-Pharmaceutical
12.16.1 BOYA Bio-Pharmaceutical Corporation Information
12.16.2 BOYA Bio-Pharmaceutical Description and Business Overview
12.16.3 BOYA Bio-Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.16.4 BOYA Bio-Pharmaceutical Products Offered
12.16.5 BOYA Bio-Pharmaceutical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Plasma Derived Medicine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Plasma Derived Medicine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Plasma Derived Medicine Market Segments
Table 2. Ranking of Global Top Plasma Derived Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Plasma Derived Medicine Market Size Growth Rate 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Albumin
Table 5. Major Manufacturers of Coagulation Factor
Table 6. Major Manufacturers of Immunoglobulin
Table 7. Major Manufacturers of Others
Table 8. Global Plasma Derived Medicine Market Size Growth Rate 5 2020-2026 (K MT)
Table 9. Global Plasma Derived Medicine Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Plasma Derived Medicine Sales by Regions 2015-2020 (K MT)
Table 11. Global Plasma Derived Medicine Sales Market Share by Regions (2015-2020)
Table 12. Global Plasma Derived Medicine Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Plasma Derived Medicine Sales Forecast by Region (2021-2026) (K MT)
Table 14. Global Plasma Derived Medicine Sales by Manufacturers (2015-2020) (K MT)
Table 15. Global Plasma Derived Medicine Sales Share by Manufacturers (2015-2020)
Table 16. Global Plasma Derived Medicine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Plasma Derived Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma Derived Medicine as of 2019)
Table 18. Plasma Derived Medicine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Plasma Derived Medicine Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Plasma Derived Medicine Price (2015-2020) (USD/MT)
Table 21. Plasma Derived Medicine Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Plasma Derived Medicine Product Type
Table 23. Date of International Manufacturers Enter into Plasma Derived Medicine Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Plasma Derived Medicine Sales (2015-2020) (K MT)
Table 26. Global Plasma Derived Medicine Sales Share (2015-2020)
Table 27. Global Plasma Derived Medicine Revenue (2015-2020) (US$ Million)
Table 28. Global Plasma Derived Medicine Revenue Share (2015-2020)
Table 29. Plasma Derived Medicine Average Selling Price (ASP) 2015-2020 (USD/MT)
Table 30. Global Plasma Derived Medicine Sales Share (2021-2026)
Table 31. Global Plasma Derived Medicine Sales 5 (2015-2020) (K MT)
Table 32. Global Plasma Derived Medicine Sales Share 5 (2015-2020)
Table 33. Global Plasma Derived Medicine Sales Share 5 (2021-2026)
Table 34. Global Plasma Derived Medicine Sales Market Share Forecast 5 (2021-2026)
Table 35. Global Plasma Derived Medicine Revenue 5 (2015-2020) (US$ Million)
Table 36. Global Plasma Derived Medicine Revenue Market Share Forecast 5 (2021-2026)
Table 37. Plasma Derived Medicine Sales (K MT) of Key Companies (2015-2020)
Table 38. Plasma Derived Medicine Sales Share by Company (2015-2020)
Table 39. Plasma Derived Medicine Revenue (US$ Million) by Company (2015-2020)
Table 40. Plasma Derived Medicine Sales (K MT) (2015-2020)
Table 41. Plasma Derived Medicine Sales Share (2015-2020)
Table 42. Plasma Derived Medicine Revenue (US$ Million) Market Share (2015-2020)
Table 43. Plasma Derived Medicine Price (K MT) (2015-2020)
Table 44. Plasma Derived Medicine Sales (K MT) (2021-2026)
Table 45. Plasma Derived Medicine Sales Share (2021-2026)
Table 46. Plasma Derived Medicine Revenue (US$ Million) Market Share (2021-2026)
Table 47. Plasma Derived Medicine Revenue Share (2021-2026)
Table 48. Plasma Derived Medicine Price (K MT) (2021-2026)
Table 49. Plasma Derived Medicine Sales (K MT) 5 (2015-2020)
Table 50. Plasma Derived Medicine Sales Share 5 (2015-2020)
Table 51. Plasma Derived Medicine Revenue (US$ Million) Market Share 5 (2015-2020)
Table 52. Plasma Derived Medicine Sales (K MT) 5 (2021-2026)
Table 53. Plasma Derived Medicine Sales Share 5 (2021-2026)
Table 54. Plasma Derived Medicine Revenue (US$ Million) Market Share 5 (2021-2026)
Table 55. Plasma Derived Medicine Revenue Share 5 (2021-2026)
Table 56. North America Plasma Derived Medicine Sales by Country (2015-2020) (K MT)
Table 57. North America Plasma Derived Medicine Sales Market Share by Country (2015-2020)
Table 58. North America Plasma Derived Medicine Revenue by Country (2015-2020) (US$ Million)
Table 59. North America Plasma Derived Medicine Revenue Market Share by Country (2015-2020)
Table 60. Europe Plasma Derived Medicine Sales by Country (2015-2020) (K MT)
Table 61. Europe Plasma Derived Medicine Sales Market Share by Country (2015-2020)
Table 62. Europe Plasma Derived Medicine Revenue by Country (2015-2020) (US$ Million)
Table 63. Europe Plasma Derived Medicine Revenue Market Share by Country (2015-2020)
Table 64. Asia Pacific Plasma Derived Medicine Sales by Region (2015-2020) (K MT)
Table 65. Asia Pacific Plasma Derived Medicine Sales Market Share by Region (2015-2020)
Table 66. Asia Pacific Plasma Derived Medicine Revenue by Region (2015-2020) (US$ Million)
Table 67. Asia Pacific Plasma Derived Medicine Revenue Market Share by Region (2015-2020)
Table 68. Latin America Plasma Derived Medicine Sales by Country (2015-2020) (K MT)
Table 69. Latin America Plasma Derived Medicine Sales Market Share by Country (2015-2020)
Table 70. Latin Americaa Plasma Derived Medicine Revenue by Country (2015-2020) (US$ Million)
Table 71. Latin America Plasma Derived Medicine Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Plasma Derived Medicine Sales by Country (2015-2020) (K MT)
Table 73. Middle East and Africa Plasma Derived Medicine Sales Market Share by Country (2015-2020)
Table 74. Middle East and Africa Plasma Derived Medicine Revenue by Country (2015-2020) (US$ Million)
Table 75. Middle East and Africa Plasma Derived Medicine Revenue Market Share by Country (2015-2020)
Table 76. Grifols Corporation Information
Table 77. Grifols Description and Business Overview
Table 78. Grifols Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Grifols Plasma Derived Medicine Product
Table 80. Grifols Recent Development
Table 81. SK Plasma Corporation Information
Table 82. SK Plasma Description and Business Overview
Table 83. SK Plasma Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. SK Plasma Product
Table 85. SK Plasma Recent Development
Table 86. Fusion Health Care Corporation Information
Table 87. Fusion Health Care Description and Business Overview
Table 88. Fusion Health Care Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Fusion Health Care Product
Table 90. Fusion Health Care Recent Development
Table 91. Biotest AG Corporation Information
Table 92. Biotest AG Description and Business Overview
Table 93. Biotest AG Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Biotest AG Product
Table 95. Biotest AG Recent Development
Table 96. GC Pharma Corporation Information
Table 97. GC Pharma Description and Business Overview
Table 98. GC Pharma Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. GC Pharma Product
Table 100. GC Pharma Recent Development
Table 101. Baxter International Corporation Information
Table 102. Baxter International Description and Business Overview
Table 103. Baxter International Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Baxter International Product
Table 105. Baxter International Recent Development
Table 106. LFB Corporation Information
Table 107. LFB Description and Business Overview
Table 108. LFB Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. LFB Product
Table 110. LFB Recent Development
Table 111. Octapharma AG Corporation Information
Table 112. Octapharma AG Description and Business Overview
Table 113. Octapharma AG Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Octapharma AG Product
Table 115. Octapharma AG Recent Development
Table 116. CSL Limited Corporation Information
Table 117. CSL Limited Description and Business Overview
Table 118. CSL Limited Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. CSL Limited Product
Table 120. CSL Limited Recent Development
Table 121. BPL Corporation Information
Table 122. BPL Description and Business Overview
Table 123. BPL Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. BPL Product
Table 125. BPL Recent Development
Table 126. China Biologic Products Corporation Information
Table 127. China Biologic Products Description and Business Overview
Table 128. China Biologic Products Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 129. China Biologic Products Product
Table 130. China Biologic Products Recent Development
Table 131. Kedrion Biopharma Corporation Information
Table 132. Kedrion Biopharma Description and Business Overview
Table 133. Kedrion Biopharma Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 134. Kedrion Biopharma Product
Table 135. Kedrion Biopharma Recent Development
Table 136. RAAS Corporation Information
Table 137. RAAS Description and Business Overview
Table 138. RAAS Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 139. RAAS Product
Table 140. RAAS Recent Development
Table 141. Tiantan Bio Corporation Information
Table 142. Tiantan Bio Description and Business Overview
Table 143. Tiantan Bio Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 144. Tiantan Bio Product
Table 145. Tiantan Bio Recent Development
Table 146. Hualan Biological Engineering Corporation Information
Table 147. Hualan Biological Engineering Description and Business Overview
Table 148. Hualan Biological Engineering Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 149. Hualan Biological Engineering Product
Table 150. Hualan Biological Engineering Recent Development
Table 151. BOYA Bio-Pharmaceutical Corporation Information
Table 152. BOYA Bio-Pharmaceutical Description and Business Overview
Table 153. BOYA Bio-Pharmaceutical Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 154. BOYA Bio-Pharmaceutical Product
Table 155. BOYA Bio-Pharmaceutical Recent Development
Table 156. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 157. Key Challenges
Table 158. Market Risks
Table 159. Main Points Interviewed from Key Plasma Derived Medicine Players
Table 160. Plasma Derived Medicine Customers List
Table 161. Plasma Derived Medicine Distributors List
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Plasma Derived Medicine Product Picture
Figure 2. Global Plasma Derived Medicine Sales Market Share in 2020 & 2026
Figure 3. Albumin Product Picture
Figure 4. Coagulation Factor Product Picture
Figure 5. Immunoglobulin Product Picture
Figure 6. Others Product Picture
Figure 7. Global Plasma Derived Medicine Sales Market Share 5 in 2020 & 2026
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Other
Figure 11. Plasma Derived Medicine Report Years Considered
Figure 12. Global Plasma Derived Medicine Market Size 2015-2026 (US$ Million)
Figure 13. Global Plasma Derived Medicine Sales 2015-2026 (K MT)
Figure 14. Global Plasma Derived Medicine Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Plasma Derived Medicine Sales Market Share by Region (2015-2020)
Figure 16. Global Plasma Derived Medicine Sales Market Share by Region in 2019
Figure 17. Global Plasma Derived Medicine Revenue Market Share by Region (2015-2020)
Figure 18. Global Plasma Derived Medicine Revenue Market Share by Region in 2019
Figure 19. Global Plasma Derived Medicine Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Plasma Derived Medicine Revenue in 2019
Figure 21. Plasma Derived Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Plasma Derived Medicine Sales Market Share (2015-2020)
Figure 23. Global Plasma Derived Medicine Sales Market Share in 2019
Figure 24. Global Plasma Derived Medicine Revenue Market Share (2015-2020)
Figure 25. Global Plasma Derived Medicine Revenue Market Share in 2019
Figure 26. Global Plasma Derived Medicine Market Share by Price Range (2015-2020)
Figure 27. Global Plasma Derived Medicine Sales Market Share 5 (2015-2020)
Figure 28. Global Plasma Derived Medicine Sales Market Share 5 in 2019
Figure 29. Global Plasma Derived Medicine Revenue Market Share 5 (2015-2020)
Figure 30. Global Plasma Derived Medicine Revenue Market Share 5 in 2019
Figure 31. Plasma Derived Medicine Sales Growth Rate 2015-2026 (K MT)
Figure 32. Plasma Derived Medicine Revenue Growth Rate 2015-2026 (US$ Million)
Figure 33. Plasma Derived Medicine Market Share in Global Market 2015-2026
Figure 34. 5 and 10 Largest Plasma Derived Medicine Players Market Share by Revenue in Plasma Derived Medicine in 2019
Figure 35. Plasma Derived Medicine Revenue Share (2015-2020)
Figure 36. Plasma Derived Medicine Revenue Growth Rate in 2015 & 2019
Figure 37. Plasma Derived Medicine Revenue Share 5 (2015-2020)
Figure 38. Plasma Derived Medicine Revenue Growth Rate 5 in 2015 & 2019
Figure 39. North America Plasma Derived Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 40. North America Plasma Derived Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. North America Plasma Derived Medicine Sales Market Share by Country in 2019
Figure 42. North America Plasma Derived Medicine Revenue Market Share by Country in 2019
Figure 43. United States Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 44. United States Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Canada Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 46. Canada Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Mexico Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 48. Mexico Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Europe Plasma Derived Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 50. Europe Plasma Derived Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 51. Europe Plasma Derived Medicine Sales Market Share by Country in 2019
Figure 52. Europe Plasma Derived Medicine Revenue Market Share by Country in 2019
Figure 53. Germany Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 54. Germany Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. France Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 56. France Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. UK Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 58. UK Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Italy Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 60. Italy Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Russia Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 62. Russia Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Asia Pacific Plasma Derived Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 64. Asia Pacific Plasma Derived Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 65. Asia Pacific Plasma Derived Medicine Sales Market Share by Region in 2019
Figure 66. Asia Pacific Plasma Derived Medicine Revenue Market Share by Region in 2019
Figure 67. China Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 68. China Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Japan Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 70. Japan Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. South Korea Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 72. South Korea Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. India Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 74. India Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Australia Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 76. Australia Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 78. Indonesia Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 80. Thailand Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 82. Malaysia Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 84. Philippines Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 86. Vietnam Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Latin America Plasma Derived Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 88. Latin America Plasma Derived Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Plasma Derived Medicine Sales Market Share by Country in 2019
Figure 90. Latin America Plasma Derived Medicine Revenue Market Share by Country in 2019
Figure 91. Brazil Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Middle East and Africa Plasma Derived Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 94. Middle East and Africa Plasma Derived Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 95. Middle East and Africa Plasma Derived Medicine Sales Market Share by Country in 2019
Figure 96. Middle East and Africa Plasma Derived Medicine Revenue Market Share by Country in 2019
Figure 97. Turkey Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 98. Turkey Plasma Derived Medicine Revenue Growth Rat
  • Global mRNA Vaccines & Therapeutics Market Growth (Status and Outlook) 2020-2025
    Published: 30-Sep-2020        Price: US 3660 Onwards        Pages: 119
    According to this study, over the next five years the mRNA Vaccines & Therapeutics market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in mRNA Vaccines & Therapeutics business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Vaccines & Therapeutic......
  • Investigation Report on Chinese Recombinant Human Erythropoietin (rhEPO) Market, 2020-2024
    Published: 30-Sep-2020        Price: US 2600 Onwards        Pages: 50
    Description There are approximately 400,000 to one million people with hemophilia in the world. Among them, there are about 100,000 to 200,000 patients in China. The registered hemophilia patients in China are less than 20,000, because most patients give up treatment due to the expensive medical expenses. Those who lack coagulation factor VIII account for 80% to 85% of the hemophilia A patients. Currently, there is no cure for hemophilia, treatment for which on the market are all alternati......
  • Global Cetrimide Market Growth 2020-2025
    Published: 30-Sep-2020        Price: US 3660 Onwards        Pages: 137
    According to this study, over the next five years the Cetrimide market will register a 5.7%% CAGR in terms of revenue, the global market size will reach $ 326.2 million by 2025, from $ 261.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cetrimide business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Cetrimide market by product type, application,......
  • Global Antivenom Market Growth 2020-2025
    Published: 30-Sep-2020        Price: US 3660 Onwards        Pages: 162
    According to this study, over the next five years the Antivenom market will register a 4.3%% CAGR in terms of revenue, the global market size will reach $ 1032.7 million by 2025, from $ 871.8 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Antivenom business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Antivenom market by product type, application......
  • Global Swine Vaccines Market Growth 2020-2025
    Published: 30-Sep-2020        Price: US 3660 Onwards        Pages: 167
    According to this study, over the next five years the Swine Vaccines market will register a 4.1%% CAGR in terms of revenue, the global market size will reach $ 1470.5 million by 2025, from $ 1249.8 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Swine Vaccines business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Swine Vaccines market by product t......
  • Global Pediatrics Hearing Aids Market Growth 2020-2025
    Published: 30-Sep-2020        Price: US 3660 Onwards        Pages: 162
    According to this study, over the next five years the Pediatrics Hearing Aids market will register a 8.6%% CAGR in terms of revenue, the global market size will reach $ 2395.7 million by 2025, from $ 1721.7 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pediatrics Hearing Aids business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Pediatrics Heari......
  • Global Rho Associated Protein Kinase 2 Market Growth (Status and Outlook) 2020-2025
    Published: 30-Sep-2020        Price: US 3660 Onwards        Pages: 116
    According to this study, over the next five years the Rho Associated Protein Kinase 2 market will register a 20.8%% CAGR in terms of revenue, the global market size will reach $ 270.1 million by 2025, from $ 126.8 million in 2019. In particular, this report presents the global revenue market share of key companies in Rho Associated Protein Kinase 2 business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Rho Associate......
  • Global Hyperimmune Globulins Market Growth 2020-2025
    Published: 30-Sep-2020        Price: US 3660 Onwards        Pages: 163
    According to this study, over the next five years the Hyperimmune Globulins market will register a 7.3%% CAGR in terms of revenue, the global market size will reach $ 2120.1 million by 2025, from $ 1600.5 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Hyperimmune Globulins business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Hyperimmune Globulin......
  • Global Internal Nasal Dilators Market Growth 2020-2025
    Published: 30-Sep-2020        Price: US 3660 Onwards        Pages: 164
    According to this study, over the next five years the Internal Nasal Dilators market will register a 10.0%% CAGR in terms of revenue, the global market size will reach $ 17 million by 2025, from $ 12 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Internal Nasal Dilators business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Internal Nasal Dilators......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs